Evidence map›Paper›PMID 30345318›Full record

ReviewJournal of immunology research2018

Biological Properties and the Role of IL-25 in Disease Pathogenesis.

Yuwan Liu, Zewei Shao, Guoqiang Shangguan, Qingli Bie, Bin Zhang

Open access · goldAbstract readReview
In one paragraph

Review in Journal of immunology research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Interleukins in Epilepsy: Friend or Foe.Neuroscience bulletin · 2024
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yuwan LiuDepartment of Laboratory Medicine, Affiliated Hospital of Jining Medical University, Jining, Shandong, China.
Zewei ShaoInstitute of Forensic Medicine and Laboratory Medicine, Jining Medical University, Jining, Shandong, China.
Guoqiang ShangguanInstitute of Forensic Medicine and Laboratory Medicine, Jining Medical University, Jining, Shandong, China.ORCID 0000-0002-2913-2758
Qingli BieDepartment of Laboratory Medicine, Affiliated Hospital of Jining Medical University, Jining, Shandong, China.ORCID 0000-0002-8097-2701
Bin ZhangDepartment of Laboratory Medicine, Affiliated Hospital of Jining Medical University, Jining, Shandong, China.ORCID 0000-0002-2879-379X
Affiliated Hospital of Jining Medical University · CNJining Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interleukin- (IL-) 17 superfamily, a T cell-derived cytokine, consists of 6 ligands (IL-17A-IL-17F) and 5 receptors (IL-17RA-IL-17RE). IL-17A, a prototype member of this family, is involved in the pathogenesis of allergies, autoimmune diseases, allograft transplantations, and malignancies. By contrast, IL-17B is reported to be closely related to certain diseases, particularly tumors such as breast cancer, gastric cancer, and pancreatic cancer. Recently, the biological function of IL-17E (also called IL-25) in disease, particularly airway diseases, has attracted the attention of researchers. However, studies on IL-25 are scant. In this review, we detail the structural characteristics, expression patterns, responder cells, biological properties, and role of IL-25 in disease pathogenesis.

Indexed as

AnimalsAutoimmune DiseasesGraft RejectionHumansInterleukin-17Molecular StructureNeoplasmsReceptors, InterleukinRespiratory Tract DiseasesSignal TransductionTranscriptomeIL-25 receptor protein, humanInterleukin-17Receptors, Interleukin

Identifiers

PMID30345318
PMCPMC6174801
OpenAlexW2894134716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.